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Abstract 
The endogenous fibrinolytic system is important for preventing occluding thrombosis and subsequent tissue 
infarction. The main activator of the fibrinolytic system in the vascular compartment is tissue-type plasminogen 
activator (t-PA). In a clotting situation, this enzyme is acutely released from storage pools in the endothelium 
and initiates fibrin breakdown. The endothelial release capacity of t-PA can be impaired by genetic or functional 
means and this impairment has been found to be associated with an increased risk for ischemic vascular disease, 
including myocardial infarction. Hypertension, smoking, and atherosclerosis are among the conditions 
associated with reduced t-PA production and release.  
Another condition that could potentially be associated with reduced fibrinolysis is inflammation, but the role of 
inflammation in the regulation of t-PA production has not been clearly established. Thus, we investigated the 
effect of the pro-inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-
6 (IL-6) on the production of t-PA in cultured human vascular endothelial cells. We also studied which 
intracellular signaling mechanisms are of importance. TNF-α and IL-1β both caused a significant reduction of t-
PA mRNA and protein production in endothelial cells. This effect was most evident at time points ≥24 h. 
Pharmacological blocking of selected intracellular signaling pathways revealed a central role of NFκB signaling 
in mediating the pro-inflammatory cytokine reduction of t-PA. p38 MAPK signaling was also found to be of 
some importance. IL-6, on the other hand, did not cause an effect on t-PA production. In fact, further 
experiments showed that the endothelial cell model used does not express a complete receptor for IL-6. However 
a soluble form of the IL-6 receptor exists in the circulation and when present in the cultures, a suppressive role of 
IL-6 on t-PA production was detected. 
Given the central role of t-PA in the fibrinolytic system and the fact that impaired t-PA production is associated 
with increased risk of atherothrombotic events, a pharmacological means to increase the production of this 
enzyme could be desirable. There are indications that t-PA production could be partly regulated by epigenetic 
mechanisms, mainly histone acetylation. We thus investigated a panel of clinically used histone deacetylase 
inhibitors (HDACis) to determine their effect on t-PA production in vitro. All HDACis tested, irrespective of 
chemical structural class, potently stimulated endothelial t-PA production indicating that it is indeed their ability 
to modulate histone acetylation that affects t-PA synthesis. This was further supported by the fact that the 
HDACi valproic acid affected endothelial histone acetylation status, both globally and also specifically around 
the t-PA transcription start site, although in initial siRNA experiments we were unable to identify which specific 
HDAC enzyme(s) were of importance. 
In conclusion, these data suggest that t-PA production in cultured vascular endothelial cells is suppressed by 
prolonged exposure to the inflammatory cytokines TNF-α and IL-1β. Moreover, IL-6, in the presence of its 
soluble receptor, can also attenuate t-PA production. If these results hold true also in vivo, it could be of 
importance e.g. in the local environment surrounding the inflammatory atherosclerotic plaque where these 
cytokines are present in high concentrations and where a sufficient t-PA production could be of uttermost 
importance. Clinically used HDACis potently stimulate t-PA in our experimental in vitro model, apparently via 
their effects on HDAC enzymes. As such, these substances could perhaps be considered for pharmacological 
stimulation of the endogenous fibrinolytic system as a novel prevention strategy for ischemic vascular disease.  
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